Dramavit

Quick links to important sections

Dramavit

Method of action: Antiemetic

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dramavit

Property Description
Active ingredient Dimenhydrinate
Form Oral preparation (Tablet)
Pharmacological class First-generation Antihistamine / Anti-emetic Agent
Common use Relief of symptoms associated with motion sickness
Origin Synthetic Compound

Dramavit is a readily available, synthetic medication classified primarily as a first-generation antihistamine and an anti-emetic agent, derived from its sole active ingredient, Dimenhydrinate. It is available as an oral preparation, typically in tablet form. This product is widely recognized for its clinical use in managing the body's adverse reactions to motion stimuli, positioning it as a foundational anti-motion sickness compound.


What Type of Medicine is Dramavit (Dimenhydrinate)?

Dramavit's active component, Dimenhydrinate, defines it as a synthetic compound belonging to the chemical subgroup of ethanolamine derivatives. The substance itself is chemically unique; it is structured as a combination drug formed by a salt of two distinct components: Diphenhydramine, which delivers the core therapeutic effect, and 8-chlorotheophylline (Theoclate). This specific composition results in a stable pharmacological profile. The classification as a first-generation antihistamine is crucial, as this indicates its established ability to exert action within the Central Nervous System (CNS), a necessary feature for its intended effects on balance and nausea pathways.


The General Purpose of Dramavit

The general purpose of Dramavit is to serve as an antivertigo agent, mitigating the discomfort caused by abnormal or conflicting sensory input related to motion. Dimenhydrinate is used as an over-the-counter medicine for the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. The medicine's function is to stabilize the body's internal reaction to movement, which is critical in conditions like kinestosis (motion sickness), a situation commonly encountered during air or sea travel. By generally suppressing the signals that trigger central reactions, the drug aids in the relief of common, disruptive symptoms such as acute nausea, vomiting, and dizziness.


How Does Dramavit's Class Define Its Action?

Dramavit's pharmacological class defines its action through both Histamine H1 receptor antagonism and significant anticholinergic action within the nervous system. This dual central mechanism facilitates the drug's primary benefit: the inhibition of the vestibular system, the inner ear apparatus responsible for sending balance information to the brain. The drug acts by affecting chemicals in the brain and inner ear associated with nausea and dizziness.

Regulatory References

  1. Dimenhydrinate: MedlinePlus Drug Information
  2. Dimenhydrinate Tablet Label - DailyMed (FDA/NIH)
  3. Dimenhydrinate - LiverTox - NCBI Bookshelf (NIH)

What side effects are possible with Dramavit?

Possible side effects and safety information

The safety profile for Dimenhydrinate is characterized primarily by effects on the central nervous and gastrointestinal systems, stemming from its classification as a first-generation antihistamine. All information on adverse reactions is based on official regulatory documentation.


Official Adverse Reaction Frequencies

Side effects are classified by how frequently they occur, according to regulatory standards:

  • Very Common (Affecting ge 1 in 10 persons): Somnolence (Drowsiness).
  • Common (Affecting ge 1 in 100 persons): Dizziness, Dry mouth, and Asthenia (Weakness).
  • Uncommon (Affecting ge 1 in 1,000 persons): Abnormal coordination, Blurred vision, Hypotension, Tachycardia, Headache, Tremor, Urinary retention, Rash, and Constipation.

Systemic and Serious Effects

Commonly reported effects involve the Nervous System (e.g., drowsiness, dizziness) and Gastrointestinal Disorders (e.g., dry mouth, stomach upset). Effects such as Tachycardia (fast heartbeat) and Hypotension are documented for the Cardiovascular System.

Serious reactions, while uncommon, include Convulsions and Respiratory Depression, which are primarily associated with overdosage. Hypersensitivity reactions, including Angioedema, are also documented in the official safety profile.


Population-Specific Safety Notes

The official labeling notes specific safety considerations for certain groups:

  • Elderly: This population may experience increased susceptibility to dizziness, sedation, and hypotension.
  • Pediatric Patients: These individuals may exhibit paradoxical CNS stimulation, such as excitation or nervousness.
  • Pregnancy/Lactation: Small amounts of the drug are known to be excreted in breast milk, and use during pregnancy is advised only if clearly needed.

Time-Related Patterns and Constraints

Official safety information states that the sedative effects may diminish after a few days of treatment initiation. Furthermore, tolerance to the drug's effects may develop with continuous use. The label highlights that the drug may impair the ability to drive or operate machinery and can have an additive sedative effect when used with alcohol or other central nervous system depressants.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The information below is strictly based on the official prescribing information for Dimenhydrinate (Dramavit) as documented by government regulatory bodies.

Overdosage may manifest through symptoms involving the Central Nervous System (CNS) and strong anticholinergic effects. CNS symptoms can include a paradoxical state, ranging from drowsiness and CNS depression to excitement, hallucinations, restlessness, and convulsions. Officially documented anticholinergic signs include tachycardia (rapid heartbeat), dry mouth, dilated pupils (mydriasis), and pyrexia (fever).

Documented Severe Outcomes

Official labeling records severe manifestations requiring immediate intervention, such as coma, circulatory collapse, respiratory depression, and ventricular dysrhythmias. The final, severe outcome of death is also documented, particularly in the context of pediatric overdosage.

Immediate Actions Required

It is mandatory to seek emergency medical attention or contact a Poison Control Center immediately upon suspicion of overdose. Treatment is generally symptomatic and supportive, as no specific antidote is known for dimenhydrinate overdose. Specific supportive measures, such as gastric lavage and close monitoring of body temperature, are officially described for managing toxicity.

Population-Specific Considerations

Regulatory documents emphasize that CNS stimulation is particularly likely in pediatric patients, where overdosage carries a heightened risk of convulsions and death. In elderly patients, symptoms such as dizziness, sedation, and hypotension are more probable.

Therapeutic Uses of Dramavit

Dramavit is applied across domains where additional symptomatic support is needed. This medicine is commonly used to help with symptoms related to physical discomfort, such as nausea, vomiting, and dizziness caused by motion sickness. It contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability.

It is relevant for conditions involving episodic or fluctuating manifestations, covering situations involving symptoms that create noticeable physiological strain and interfere with daily functioning. Dramavit is applied in addressing these symptom clusters, particularly when symptoms intensify and supportive relief is needed. This supportive role helps ease the overall symptom burden during difficult episodes. The goal is to help improve day-to-day comfort during symptomatic periods.

Quick Fact: Symptom Management
Dramavit is commonly used when short-term symptomatic assistance is needed in contexts involving heightened systemic burden.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Dramavit?

The population eligibility for Dramavit (Dimenhydrinate) is strictly defined by regulatory documents, establishing absolute prohibitions and requirements for conditional use.

Absolute Prohibitions (Contraindications)

Dramavit is contraindicated and must not be used in specific groups, including individuals with a known hypersensitivity or allergic reaction to dimenhydrinate or its component, diphenhydramine. Use is also prohibited in neonates, premature infants, and children under 2 years of age for over-the-counter (OTC) use. Regulatory labels prohibit use in patients with narrow-angle glaucoma or conditions aggravated by anticholinergic effects, such as prostatic hypertrophy.

Eligibility by Age Group and Physiological State

Age Group / State Regulatory Status
Children 2 years and older Approved for use (OTC).
Older Adults (Geriatric) Use with caution; generally not recommended due to increased risk of sedation.
Pregnancy FDA Category B; use only if clearly needed.
Lactation Excreted in human milk; caution required.

Eligibility is restricted in patients with certain conditions like chronic bronchitis, cardiac arrhythmias, or seizure disorders, requiring consultation and caution due to the potential for aggravation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Dramavit (Dimenhydrinate) is defined by its potential for additive effects when co-administered with other substances, alongside specific combinations that are formally prohibited by regulatory authorities.


Documented Pharmacodynamic Interactions

Interacting Class/Substance Official Regulatory Statement Restriction
Central Nervous System (CNS) Depressants Produces an additive sedative effect when co-administered. This includes sedatives, hypnotics, opioids, and other sedating antihistamines. Use with caution.
Anticholinergic Drugs Results in the intensification of anticholinergic symptoms such as dry mouth and urinary retention. Use with caution.
Ototoxic Medications Capable of masking symptoms of ototoxicity (inner ear damage) caused by drugs like aminoglycoside antibiotics. Monitor closely.
Alcohol (Ethanol) Concomitant use may have an additive effect increasing drowsiness, and should be avoided. Avoid use.

Formally Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated because MAOIs prolong and intensify the anticholinergic effects of dimenhydrinate. Regulatory guidance mandates a time separation, requiring Dramavit to be avoided during or within 14 days following MAOI therapy. Additionally, the drug is formally contraindicated in patients with Porphyria and in Neonates and Premature Infants, a restriction linked to potential formulation risk. The elderly population is noted as being more likely to experience intensified interaction outcomes such as sedation.

Mechanism of Action

Antagonism of the H1 Receptor in the CNS

Dramavit functions as a competitive antagonist of the histamine H1 receptor. This action inhibits the binding of endogenous free histamine, primarily within the central nervous system (CNS), which is independent of the compound's peripheral H1 receptor activity. The resultant molecular blockade of H1 receptors consequentially modulates downstream neuronal signaling pathways related to arousal and consciousness.


Modulation of Vestibular Cholinergic Signaling

Additionally, the compound exhibits anticholinergic properties through its activity at muscarinic receptors. This interaction acts to inhibit cholinergic input directed toward the vestibular nuclei, which are fundamental centers for processing information related to balance and spatial orientation. By suppressing this specific efferent and afferent signaling, Dramavit subsequently modulates the neural processing that regulates posture and equilibrium.

Dosage and Administration Information

How Dramavit is Used: Administration Guidelines

Dramavit (Dimenhydrinate) is utilized according to established protocols that establish the required route, dose, and timing. These instructions facilitate consistent administration across different settings.


Administration Routes and Standard Dosing

The medicine is available for multiple administration routes, with the chosen method often depending on the clinical context (e.g., if vomiting prevents oral intake).

Administration Scope Dosing and Routes
Routes Oral (tablet, liquid), Intramuscular (IM), Intravenous (IV), and Rectal (suppository) are recognized methods of administration.
Standard Adult Dose The typical dose for oral, IM, or IV administration is 50 mg to 100 mg per single dose.
Maximum Daily Dose The total dose for adults must not exceed 400 mg in a 24-hour period.

Frequency and Contextual Instructions

Use is structured around a preventive rule and a time-restricted frequency, as the drug is intended for short-term, acute symptom management.

  • Preventive Timing: For the prevention of motion sickness, the initial dose is typically taken 30 minutes to 1 hour before the start of the activity.
  • Dose Frequency: Dosing may be repeated every 4 to 6 hours as needed for oral and parenteral routes.
  • IV Preparation: For intravenous use, the injectable solution is diluted (e.g., with 10 mL of 0.9% Sodium Chloride Injection) and infused slowly over a period of 2 minutes to ensure correct administration.
  • Specific Populations: Pediatric administration involves age-based dosing schedules and maximums. Older adults are advised to use with caution and may require a smaller dose.

Recent Clinical Evidence

Overview of Clinical and Preclinical Studies


Evidence Summary

Research surrounding the compound has primarily focused on its characteristics relating to inflammation and its exploration for use in joint health. The majority of studies investigated whether the compound influenced joint function and reduced pain reports in individuals with osteoarthritis. The compound's activity may involve certain inflammatory pathways. Preclinical studies examined effects on markers of joint inflammation.

Studies have focused on its use in individuals with mild-to-moderate arthritis. It is not yet clear whether studies have made direct comparisons regarding the effectiveness of different compounds.

Tolerability data was recorded in studies involving most adults.


Key Study Areas

Human Clinical Trials

Studies exploring the compound's influence on pain and function in the joints have utilized a variety of assessment tools.

Assessment Area Study Focus
Pain and Stiffness Research explored the potential for continued observation of benefit regarding pain and stiffness over a 12-week period in a randomized, controlled trial.
Joint Structure Other studies examined the impact of long-term use (up to one year) on the physical structure of the joint, such as cartilage integrity.
Onset of Effect Studies examined the onset of effect, with some reports indicating changes were observed within the first four weeks of the study period.

Preclinical Research (In Vitro and Animal Studies)

Preclinical studies often examine potential biological pathways. Research has evaluated whether the compound influences mobility in animal models of induced arthritis.

Frequently Asked Questions (FAQ)

Common questions about Dramavit (FAQ)


Q: Is Dramavit meant to be taken every day, or only when needed?

A: Official product information indicates that Dramavit is intended for the acute management of symptoms associated with motion sickness, such as nausea and dizziness. It is typically taken only as needed for a short duration. Regulatory text also notes that continuous use may result in the body developing a tolerance to the drug's effects.


Q: How quickly does Dramavit start to work after I take it?

A: To achieve its preventive effect for motion sickness, official guidance describes that the first dose is typically administered 30 minutes to 1 hour before the start of the activity. This timeframe suggests when the medicine is expected to begin working.


Q: How long do the effects of Dramavit typically last?

A: The effects of the medicine generally last long enough to support repeat dosing. Regulatory dosing instructions often advise that the dose may be repeated every 4 to 6 hours for adults, which indicates the general duration of the drug's effect in the body.


Q: Are there any specific foods or drinks I should avoid when taking Dramavit?

A: Official regulatory warnings state that alcoholic beverages should be avoided when using this product. This is because combining the medicine with alcohol can lead to an additive sedative effect, increasing potential drowsiness and dizziness. Specific non-alcoholic foods or drinks are generally not listed as contraindications.


Q: Does Dramavit interact with common pain relievers like ibuprofen or acetaminophen?

A: Regulatory warnings typically focus on interactions with pharmacologically active drug classes such as CNS depressants and anticholinergics. Dramavit is generally not listed as having a direct interaction with common pain relievers like ibuprofen or acetaminophen. However, patients are generally advised to review the labels of all medicines they take.


Q: What does 'contraindication' mean in the context of Dramavit?

A: In regulatory terms, a contraindication refers to a specific pre-existing condition or circumstance in which Dramavit must not be used. Official documents list these prohibitions because the risk of harm or adverse effects is significantly increased.


Q: Why do some people say Dramavit causes them to feel jittery?

A: While the primary side effect is drowsiness, regulatory safety information notes that in certain populations, particularly children, the drug can cause a paradoxical effect of CNS stimulation, such as excitement or nervousness. This potential for stimulation is described as occurring occasionally in adults as well.


Q: If I miss a dose of Dramavit, should I take two doses the next time?

A: If a regular dose of the medicine is missed, the recommended guidance is to take it as soon as it is remembered. Regulatory guidance on missed doses states that taking two doses together is not recommended to make up for a single missed dose.


Q: How long should I wait after taking Dramavit before consuming alcohol?

A: Regulatory guidance requires avoiding the simultaneous use of alcohol because of the risk of additive sedation. A specific waiting period is not typically detailed, but it is understood that alcohol should be avoided while the medicine is actively present in the system, generally aligning with the recommended dosing interval.


Q: What is the recommended maximum duration for continuously taking Dramavit?

A: While the maximum duration is not always stated on the over-the-counter label, the medicine is intended for short-term, acute use. Continuous, long-term use is not generally described as necessary, and the official safety profile notes that tolerance to the drug's effects may develop over time.


Q: Is the 'Inactive Ingredient' list in Dramavit important to review?

A: Yes, the list of inactive ingredients, or excipients, should be reviewed by all patients. This information is particularly important for individuals with known allergies or sensitivities, as these components (such as fillers, binders, or coloring agents) can occasionally contain common allergens.


Q: Why does the packaging for Dramavit include a warning about kidney issues?

A: Official precautions advise that Dramavit should be used with caution in patients with renal impairment (kidney disease). The precaution is in place because the medicine is cleared by the kidneys, and impaired function may affect the drug's activity.


Q: Does taking Dramavit at night cause sleep disturbances?

A: The drug’s most common side effect is drowsiness (somnolence). While this generally leads to increased sleepiness, instances of paradoxical stimulation or nervousness, which could potentially disturb sleep, are occasionally noted, primarily in pediatric patients.


Q: Can Dramavit be used alongside herbal remedies?

A: Regulatory bodies generally advise caution when combining any medicine with herbal remedies or supplements. This is especially true for herbal products that may cause effects similar to Dramavit, such as sedation or dry mouth. Official documentation notes that combining products should be discussed with a healthcare professional.


Q: What are the signs of a serious allergic reaction to Dramavit?

A: A serious allergic reaction requires immediate medical attention. Official sources note that symptoms may include swelling of the face, eyes, lips, or tongue, difficulty breathing, or the appearance of an itchy skin rash spreading over the body.


Q: Are there different strengths of Dramavit available, and why?

A: Yes, the product is typically available in different strengths (e.g., 25 mg, 50 mg). This is to accommodate the varying dose requirements for different user groups, specifically adults and children, as regulatory guidelines establish age-based dosing schedules.


Q: What does the drug's purpose mean when it says it is 'symptomatic relief'?

A: Symptomatic relief means that the medicine works to relieve the specific symptoms—such as nausea, dizziness, and vomiting associated with motion sickness. It does not provide a cure for the underlying cause of the motion sickness itself.


Q: Is Dramavit safe to use if I have mild liver problems?

A: Official precautions note that the medicine is to be used with caution in individuals with hepatic diseases (liver problems). Because the liver is key in processing many drugs, labeling indicates that these conditions may require dose adjustments.


Q: Is Dramavit habit-forming or addictive?

A: Dramavit is not classified as a scheduled controlled substance by drug enforcement agencies. However, official information acknowledges that the potential for tolerance to its effects and psychological dependence has been noted with heavy, non-recommended use.


Q: What should I do if I suspect I've taken too much Dramavit?

A: Overdosage can lead to serious adverse effects, including convulsions. Regulatory warnings state that seeking emergency medical help or contacting a Poison Control Center is the required action in case of suspected overdose.


Q: What is the difference between the main ingredient and the excipients in Dramavit?

A: The main ingredient (Dimenhydrinate) is the active component that provides the medical effect. Excipients are the inactive ingredients, such as fillers, coloring agents, and binders, that help to form the tablet but do not contribute to the therapeutic action.


Q: How does Dramavit affect people with existing stomach sensitivity?

A: Official safety data lists gastrointestinal side effects, such as stomach upset, as commonly reported. For individuals with existing stomach sensitivities, official warnings advise that caution may be necessary. Official documents describe that individuals with these conditions may need professional guidance for use.


Q: Are there specific symptoms that mean I should stop taking Dramavit immediately?

A: Yes. If severe allergic reaction symptoms occur (like trouble breathing or swelling) or if serious CNS effects like convulsions are experienced, these symptoms are noted as requiring immediate discontinuation and emergency medical attention.


Q: Does Dramavit interact with caffeine or nicotine products?

A: Dramavit contains a component that is chemically similar to methylxanthines, a class that includes caffeine. For this reason, official sources indicate that combining the drug with products containing caffeine may lead to additive side effects such as increased restlessness or a fast heartbeat (tachycardia).


Q: Does Dramavit contain sugar, lactose, or gluten?

A: While the active ingredient itself does not contain these, specific excipients like lactose or starch (a potential source of gluten) can be present in different product forms. Patients must carefully review the inactive ingredient list on the specific product label.

How should Dramavit be stored and disposed of?

Storage Requirements for Dramavit (Dimenhydrinate)

Storage Condition Regulatory Requirement
Temperature Store at controlled room temperature (20 C to 25 C), allowing excursions up to 30 C.
Environmental Protect from moisture and store in a dry place. Do not freeze the product.
Container Keep in the original container and ensure the container is tightly closed.
Safety Store the medication out of the sight and reach of children.

Disposal Instructions

To discard expired or unused Dramavit tablets, follow local regulations for pharmaceutical waste handling. The product must not be flushed down the toilet or thrown into household garbage unless specifically authorized by local disposal programs. Always check the expiration date before use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dramavit found in:

A-Z Index: